SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-077642
Filing Date
2022-12-05
Accepted
2022-12-05 16:30:26
Documents
3
Period of Report
2022-12-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea169609-6k_altamira.htm 6-K 22381
2 PURCHASE AGREEMENT, DATED AS OF DECEMBER 5, 2022, BY AND BETWEEN ALTAMIRA THERAP ea169609ex10-1_altamira.htm EX-10.1 304402
3 REGISTRATION RIGHTS AGREEMENT, DATED AS OF DECEMBER 5, 2022, BY AND BETWEEN ALTA ea169609ex10-2_altamira.htm EX-10.2 88540
  Complete submission text file 0001213900-22-077642.txt   416673
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 221445319
SIC: 2834 Pharmaceutical Preparations